Dr. Canuso foot repair serum

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Dr. Canuso foot repair serum
Generic name: TOLNAFTATE SERUM
Manufacturer: Renu Laboratories, LLC
Product type: HUMAN OTC DRUG
SPL set ID: 1fcc52c5-7030-13cb-e054-00144ff8d46c
SPL ID: 350b8fbb-d869-9503-e063-6394a90a9eb8
Version: 17
Effective date: 2025-05-13
Source export date: 2026-10-27
Source partition: 13
Source file: https://download.open.fda.gov/drug/label/drug-label-0013-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-27/6f51a1483736359ffd78ed7be27289bc51f2a8463b934465bee40efbdef4dfd7/drug-label-0013-of-0014.json.zip
Source manifest SHA-256: 6be3667a3beefe6c0ead4c723ea963050533a2bc725a8044d58b07d18b258c55
Import run: 20261027T193451Z
Imported at: 2026-10-27 21:07:23

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M005	openfda.application_number
brand name		Dr. Canuso foot repair serum	openfda.brand_name
generic name		TOLNAFTATE SERUM	openfda.generic_name
manufacturer name		Renu Laboratories, LLC	openfda.manufacturer_name
ndc	package	76348-409-02	openfda.package_ndc
ndc	product	76348-409	openfda.product_ndc
ndc11	package	76348040902	derived:openfda.package_ndc
rxcui		283693	openfda.rxcui
spl id		350b8fbb-d869-9503-e063-6394a90a9eb8	id
spl set id		1fcc52c5-7030-13cb-e054-00144ff8d46c	set_id
unii		06KB629TKV	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

When using this product Do not use on children under 2 years of age unless directed by a doctor Avoid contact with eyes If irritation occurs, discontinue use and consult a doctor If swallowed, get medical help or consult a poison control center immediately

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.